Functional neuroimaging of the dopaminergic system using dopamine transporter SPECT (DAT) differentiates nigrostriatal dopamine loss from non-degenerative conditions such as essential tremor, drug-induced parkinsonism, dystonia or functional movement disorders. This evidence concerns the gene SLC6A3 and essential tremor.